Skip to main content

Table 2 Antimicrobial susceptibility pattern of CNS isolates

From: Phenotypic and genotypic characterization of biofilm producing clinical coagulase negative staphylococci from Nepal and their antibiotic susceptibility pattern

Antibiotics Total (n = 214) S. epidermidis (n = 123) S. saprophyticus (n = 40) S. hemolyticus (n = 24) S. hominis (n = 15) S. capitis (n = 12)
R S R S R S R S R S R S
CNS
 Penicillin 196 (91.6%) 18 (8.4%) 111 (90.2%) 12 (9.8%) 39 (97.5%) 1 (2.5%) 23 (95.8%) 1 (4.2%) 12 (80%) 3 (20%) 11 (91.7%) 1 (8.3%)
 Ciprofloxacin 76 (35.5%) 138 (64.5%) 39 (31.7%) 84 (68.35) 7 (17.5%) 33 (82.5%) 17 (70.8%) 7 (29.2%) 5 (33.3%) 10 (66.75) 8 (66.7%) 4 (33.3%)
 Tetracycline 27 (12.6%) 187 (87.4%) 11 (8.9%) 112 (91.1%) 8 (20%) 32 (80%) 7 (29.2%) 17 (70.8%) 1 (6.7%) 14 (93.3%) - 12 (100%)
 Clindamycin 63 (29.4%) 151 (70.6%) 30 (24.4%) 93 (75.6%) 13 (32.5%) 27 (67.5%) 9 (37.5%) 15 (62.5%) 5 (33.3%) 10 (66.7%) 6 (50%) 6 (50%)
 Chloramphenicol 19 (8.9%) 195 (91.1%) 9 (7.3%) 114 (92.7%) 5 (12.5%) 35 (87.5%) 1 (4.2%) 23 (95.8%) 2 (13.3%) 13 (86.7%) 2 (16.7%) 10 (83.3%)
 Cefoxitin 143 (6.5%) 71 (33.2%) 73 (59.3%) 50 (40.7%) 29 (72.5%) 11 (27.5%) 21 (87.5%) 3 (12.5%) 10 (66.7%) 5 (33.3%) 10 (83.3%) 2 (16.7%)
 Erythromycin 155 (72.4%) 59 (27.6%) 80 (65%) 43 (35%) 34 (85%) 6 (15%) 21 (87.5%) 3 (12.5%) 10 (66.7%) 5 (33.3%) 10 (83.3%) 2 (16.7%)
 Cotrimoxazole 80 (37.4%) 134 (62.6%) 46 (37.4%) 77 (62.6%) 14 (35%) 26 (65%) 10 (41.7%) 14 (58.3%) 6 (40%) 9 (60%) 4 (33.3%) 8 (66.7%)
 Gentamicin 45 (21%) 169 (79%) 17 (13.8%) 106 (86.2%) 8 (20%) 32 (80%) 14 (58.3%) 10 (41.7%) 15 (100%) 6 (50%) 6 (50%)
  1. R Resistant, S Sensitive